Brenner A.I., Koshy J., Morey J., Lin C., DiPoce J. The Bone Scan. Semin Nucl Med. 2012 Jan; 42(1): 11–26. doi: 10.1053/j.semnuclmed.2011.07.005..
DOI: 10.1053/j.semnuclmed.2011.07.005

Seo Y., Mari C., Hasegawa B.H. Technological development and advances in single-photon emission computed tomography/computed tomography. Semin Nucl Med. 2008 May; 38 (3): 177–98. doi: 10.1053/j.semnuclmed.2008.01.001..
DOI: 10.1053/j.semnuclmed.2008.01.001

Wasserman J., De la Lande B., Pecking A., Brasseur A. Lepatient métastatiqueet sonenvironnement. Douleuret métastases osseuses. Prog Urol. 2008; 18 (Suppl 7): S399–409.

Крылов В.В., Цыб А.Ф., Дроздовский Б.Я. Радионуклидная терапия у больных с метастатическими поражениями костей. Медицинская радиология и радиационная безопасность. 2006; Т. 51, № 3: 65–74.

Roodman G.D. Mechanisms of bone metastasis. N Engl J Med. 2004 Apr 15; 350 (16): 1655–64.

Krishnamurthy G.T., Tubis M., Hiss J., Blahd W.H. Distribution pattern of metastatic bone disease. A need for total body skeletal image. JAMA. 1977 Jun 6; 237 (23): 2504–6.

Bauerle T., Komljenovic D., Semmler W. Monitoring molecular, functional and morphologic aspects of bone metastases using non-invasive imaging. Curr Pharm Biotechnol. 2012 Mar; 13 (4): 584–94.

Gnanasegaran G., Cook G.J., Fogelman I. Musculoskeletal system. Clinical Nuclear Medicine/Ed. H.- J. Biersack, L.M. Freeman. New York. Springer. 2007. P. 241–262. doi: 10.1007/978-3-540-28026-2..
DOI: 10.1007/978-3-540-28026-2

Wang C., Shen Y. Study on the distribution features of bone metastases in prostate cancer. Nucl Med Commun. 2012 Apr; 33 (4): 379–83. doi: 10.1097/MNM.0b013e3283504528..
DOI: 10.1097/MNM.0b013e3283504528

Biersack H.J., Knopp R., Franken Th. Emission Computed Tomography Single Photon with a rotating Scintillation Camera System (Gammatome). Darmstadt. 1980.

Beheshti M., Langsteger W., Fogelman I. Prostate Cancer: Role of SPECT and PET in Imaging Bone Metastases. Semin Nucl Med. 2009 Nov; 39 (6): 396–407. doi: 10.1053/j.semnuclmed.2009.05.003..
DOI: 10.1053/j.semnuclmed.2009.05.003

Gates G.F. SPECT bone scanning of the spine. Semin Nucl Med. 1998 Jan; 28 (1): 78–94.

Долгушин М.Б., Котельникова Т.М., Соболева О.И., Голанов А.В., Зайцева А.Ю., Радкевич Л.А., Пронин И.Н., Фадеева Л.М., Туркин А.М., Корниенко В.Н. Исследование всего тела у больных с метастазами в головной мозг: МР-ДВИ, ПЭТ и ОФЭКТ/КТ. Вестник рентгенологии и радиологии. № 4–6. 2009: 58–64.

Chua S., Gnanasegaran G., Cook G.J. Miscellaneous Cancers (Lung, Thyroid, Renal Cancer, Myeloma, and Neuroendocrine Tumors): Role of SPECT and PET in Imaging Bone Metastases. Semin Nucl Med. 2009 Nov; 39 (6): 416–30. doi: 10.1053/j.semnuclmed.2009.07.002..
DOI: 10.1053/j.semnuclmed.2009.07.002

Лысенков М.Ю., Аншелес А.А., Иванов К.П., Сергиенко В.Б. Значимость коррекции поглощения при перфузионной ОЭКТ/КТ миокарда. Радиационная онкология и ядерная медицина. 2014; 1: 59–64.

Townsend D.W. Dual-modality imaging: Combining anatomy and function. J Nucl Med. 2008 Jun; 49 (6): 938–55. doi: 10.2967/jnumed.108.051276..
DOI: 10.2967/jnumed.108.051276

Clinical applications of SPECT/CT: new hybrid nuclear medicine imaging system. IAEA; 2008. 55 p.

Madeddu G., Spanu A. Use of tomographic nuclear medicine procedures, SPECT and pinhole SPECT, with cationic lipophilic radiotracers for the evaluation of axillary lymph node status in breast cancer patients. Eur J Nucl Med Mol Imaging. 2004 Jun; 31 Suppl 1: S23–34.

Голанов А.В., Котельникова Т.М., Меликян А.Г., Долгушин М.Б., Сорокин В.С., Соболева О.И., Хохлова Е.В., Горлачев Г.Е., Краснянский С.А. Опыт использования ОФЭКТ/КТ в нейрохирургической клинике. Вопросы нейрохирургии. 2012; Т. 76, № 1: 85–91.

Hasegawa B.H., Iwata K., Wong K.H., Wu M.C., Da Silva A.J., Tang H.R., Barber W.C., Hwang A.H., Sakdinawat A.E. Dual-modality imaging of function and physiology. Acad Radiol. 2002 Nov; 9 (11): 1305–21.

El Badaoui A., de Clermont H., Valli N., Caignon J.-M., Fernandez P., Allard M., Barat J.-L., Ducassoua D. Impact diagnostique de la TEMP– TDM dans l’exploration des tumeurs endocrines. Médecine Nucléaire. 2008 Feb; Vol. 32, Issue 2: 66–75.

Wong K.K., Cahill J.M., Frey K.A., Avram A.M. Incremental Value of 111-In Pentetreotide SPECT/CT Fusion Imaging of Neuroendocrine Tumors. Acad Radiol. 2010 Mar; 17 (3): 291–7. doi: 10.1016/j.acra.2009.08.015..
DOI: 10.1016/j.acra.2009.08.015

Radiation Physics for Nuclear Medicine/Ed. by M.C. Cantone, Ch. Hoeschen. Springer-Verlag Berlin, Heidelberg; 2011. 285 p.

Bunyaviroch T., Aggarwal A., Oates M.E. Optimized scintigraphic evaluation of infection and inflammation: role of single-photon emission computed tomography/computerized tomography fusion imaging. Semin Nucl Med. 2006 Oct; 36 (4): 295–311.

Barwick T., Fernando R., Gnanasegaran G. The use of 99mTc-MDP SPECT/CT in the evaluation of indeterminate bone lesions on whole body planar imaging in cancer patients. Eur J Nucl Med Mol Imaging. 2008; 35: S155.

Bardet S., Ciappuccini R., Aide N., Barraux V., Rame J.-P. Imagerie hybride (TEMP/TDM, TEP/TDM) et cancer différencié de la thyroïde. Médecine Nucléaire. 2010 Aug; Vol. 34, Issue 8: 457–463.

Romer W., Nomayr A., Uder M., Bautz W., Kuwert T. SPECT-guided CT for evaluating foci of increased bone metabolism classified as indeterminate on SPECT in cancer patients. J Nucl Med. 2006 Jul; 47 (7): 1102–6.

Buck A.K., Nekolla S., Ziegler S., Beer A., Krause B.J., Herrmann K., Scheidhauer K., Wester H.-J., Rummeny E.J., Schwaiger M., Drzezga A. SPECT/CT. J Nucl Med. 2008 Aug; 49 (8): 1305–19. doi: 10.2967/jnumed.107.050195..
DOI: 10.2967/jnumed.107.050195

Gnanasegaran G., Cook G., Adamson K., Fogelman I. Patterns, Variants, Artifacts, and Pitfalls in Conventional Radionuclide Bone Imaging and SPECT/CT. Semin Nucl Med. 2009 Nov; 39 (6): 380–95. doi: 10.1053/j.semnuclmed.2009.07.003..
DOI: 10.1053/j.semnuclmed.2009.07.003

Эмиссионная томография. Основы ПЭТ и ОФЭКТ / Под ред. Д. Арсвольда, М. Верника. М.; 2009, 612 с.

Brouwer O.R., Noe A., Olmos R.A., Bex A. Lymphatic drainage from renal cell carcinoma along the thoracic duct visualized with SPECT/CT. Lymphat Res Biol. 2013 Dec; 11 (4): 233–8. doi: 10.1089/lrb.2013.0017..
DOI: 10.1089/lrb.2013.0017

Stoffels I., Boy C., Pöppel T., Kuhn J., Klötgen K., Dissemond J., Schadendorf D., Klode J. Association between sentinel SPECT/CT and metastatic lymph node excision with or without preoperative node detection and disease-free survival in melanoma. JAMA. 2012 Sep 12; 308 (10): 1007–14. doi: 10.1001/2012.jama.11030..
DOI: 10.1001/2012.jama.11030

Papathanassiou D., Bruna-Muraille C., Jouannaud C., Gagneux-Lemoussu L., Eschard J.P., Liehn J.C. Single-photon emission computed tomography combined with computed tomography (SPECT/CT) in bone diseases. Joint Bone Spine. 2009 Oct; 76 (5): 474–80. doi: 10.1016/j.jbspin.2009.01.016..
DOI: 10.1016/j.jbspin.2009.01.016

Vermeeren L., van der Ploeg I.M., Olmos R.A., Meinhardt W., Klop W.M., Kroon B.B., Nieweg O.E. SPECT/CT for preoperative sentinel node localization. J Surg Oncol. 2010 Feb 1; 101 (2): 184–90. doi: 10.1002/jso.21439..
DOI: 10.1002/jso.21439

Kretzschmar M., Wiewiorski M., Rasch H., Jacob A.L., Bilecen D., Walter M.A., Valderrabano V. 99mTc-DPD-SPECT/CT predicts the outcome of imaging-guided diagnostic anaesthetic injections: A prospective cohort study. Eur J Radiol. 2011 Dec; 80 (3): e410–5. doi: 10.1016/j.ejrad.2010.09.013..
DOI: 10.1016/j.ejrad.2010.09.013

Horger M., Bares R. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease. Semin Nucl Med. 2006 Oct; 36 (4): 286–94.

Schillaci J., Simonetti G. Fusion imaging in nuclear medicineapplications of dual-modality systems in oncology. Cancer Biother Radiopharm. 2004 Feb; 19 (1): 1–10.

Elgazzar A.H., Kazem N. Metastatic bone disease: evaluation by functional imaging in correlation with morphologic modalities. Gulf J Oncolog. 2009 Jan; (5): 9–21.

Gnanasegaran G., Barwick T., Adamson K., Mohan H., Sharp D., Fogelman I. Multislice SPECT/CT in Benign and Malignant Bone Disease: When the Ordinary Turns Into the Extraordinary. Semin Nucl Med. 2009 Nov;39(6):431-42. doi: 10.1053/j.semnuclmed.2009.07.005..
DOI: 10.1053/j.semnuclmed.2009.07.005

Utsunomiya D., Shiraishi S., Imuta M., Tomiguchi S., Kawanaka K., Morishita S., Awai K., Yamashita Y. Added value of SPECT/CT fusion in assessing suspected bone metastasis: Comparison with scintigraphy alone and nonfused scintigraphy and CT. Radiology. 2006 Jan; 238 (1): 264–71.

Zhao Z., Li L., Li F., Zhao L. Single photon emission computed tomography/spiral computed tomography fusion imaging for the diagnosis of bone metastasis in patients with known cancer. Skeletal Radiol. 2010Feb; 39 (2): 147–53. doi: 10.1007/s00256-009-0764-0..
DOI: 10.1007/s00256-009-0764-0

Helyar V., Mohan H.K., Barwick T., Livieratos L., Gnanasegaran G., Clarke S.E., Fogelman I. The added value of multislice SPECT/CT in patients with equivocal bony metastasis from carcinoma of the prostate. Eur J Nucl Med Mol Imaging. 2010 Apr; 37 (4): 706–13. doi: 10.1007/s00259-009-1334-3..
DOI: 10.1007/s00259-009-1334-3

Крживицкий П.И., Канаев С.В., Новиков С.Н., Жукова Л.А., Пономарева О.И., Негусторов Ю.Ф. ОФЭКТ-КТ в диагностике метастатического поражения скелета. Вопросы онкологии. 2014; Т. 60, № 1: 56–63.

Zhang Y., Shi H., Gu Y., Xiu Y., Li B., Zhu W., Chen S., Yu H. Differential diagnostic value of single- photon emission computed tomography/ spiral computed tomography with Tc-99m-methylene diphosphonate in patients with spinal lesions. Nucl Med Commun. 2011 Dec; 32 (12): 1194–200. doi: 10.1097/MNM.0b013e32834bd82e..
DOI: 10.1097/MNM.0b013e32834bd82e

Hassan F.U., Mohan H.K., Gnanasegaran G., Vijayanathan S., Fogelman I. Beware of the focal uptake at the ischium on the bone scan in prostate cancer. Nucl Med Commun. 2011; 32 (4): 320–3. doi: 10.1097/MNM.0b013e328342ff50..
DOI: 10.1097/MNM.0b013e328342ff50

Iqbal B., Currie G.M., Wheat J.M., Raza H., Kiat H. The incremental value of SPECT/CT in characterizing solitary spine lesions. J Nucl Med Technol. 2011 Sep; 39 (3): 201–7. doi: 10.2967/jnmt.111.088351..
DOI: 10.2967/jnmt.111.088351

Kuisma A.K., Jambor I., Huovinen R., Sandell M. Prospective evaluation of planar bone scintigraphy, SPECT/CT, 18F NAF PET/CT and whole body 1.5T MRI for detection of bone metastases in high risk breast and prostate cancer patients // Ann Oncol. 2012. Vol. 23 P.ix.383-ix384.

Zhang Y., Shi H., Cheng D., Jiang L., Xiu Y., Li B., Gu Y., Chen S. Added value of SPECT/spiral CT versus SPECT in diagnosing solitary spinal lesions in patients with extraskeletal malignancies. Nucl Med Commun. 2013 May; 34 (5): 451–8. doi: 10.1097/MNM.0b013e32835fa552..
DOI: 10.1097/MNM.0b013e32835fa552

Cherry S.R. Multimodality Imaging: Beyond PET/CT and SPECT/CT. Semin Nucl Med. 2009 Sep; 39 (5): 348–53. doi: 10.1053/j.semnuclmed.2009.03.001..
DOI: 10.1053/j.semnuclmed.2009.03.001

Jung J.H., Choi Y., Hong K.J., Min B.J., Choi J.Y., Choe Y.S., Lee K.H., Kim B.T. A combined gamma camera and optical imager. Phys Med Biol. 2009 Jul 21; 54 (14): 4547–59. doi: 10.1088/0031-9155/54/14/011..
DOI: 10.1088/0031-9155/54/14/011

Handler W.B., Gilbert K.M., Peng H., Chronik B.A. Simulation of scattering and attenuation of 511 keV photons in a combined PET/fieldcycled MRI system. Phys Med Biol. 2006 May 21; 51 (10): 2479–91.

Исакова М.Е. Проблема боли в онкологии. Русский медицинский журнал. 2000; Т. 8, № 17: 723–726.

Hara N., Onoguchi M., Takenaka K., Matsubara K., Ujita H., Kenko Y. Assessment of Patient Exposure to X-Radiation from SPECT/CT Scanners. J Nucl Med Technol. 2010 Sep; 38(3): 138–48. doi: 10.2967/jnmt.110.075770..
DOI: 10.2967/jnmt.110.075770